March 2021

Volume 21 Issue 3

Editorial Staff

Clinical Editor
Bradley Knight, MD
Executive Editor
Laurie Gustafson
Managing Editor
Jodie Elrod
Production Manager
Alexa Flinn

Editorial Correspondence

Jodie Elrod, Managing Editor, EP Lab Digest
HMP Communications, 70 E. Swedesford Rd
Suite 100, Malvern PA 19355
Telephone: (800) 371-0791

Fax: (866) 488-8273
This new energy source has the potential to quickly and permanently create transmural ablation lesions in a manner that could be highly selective for heart muscle, avoiding the risks of collateral injury to the esophagus and phrenic nerve.
Giuseppe Lanzillo, MD and colleagues describe the rate of complications secondary to permanent pacemaker (PPM) implantation after transcatheter aortic valve implantation (TAVI).
Christopher Purtell, MD, and Miguel Leal, MD share 2 cases demonstrating different approaches to dealing with lead malfunction after LVAD implantation.
Serkan Cay, MD and colleagues describe a case requiring left lateral epicardial VT ablation and left phrenic nerve (PN) displacement using a sizing balloon to prevent PN injury.
Ven Gee Lim, MBChB (Hons), MSc, MRCP and colleagues present a novel case of a 42-year-old male with an unusual substrate for RVOT tachycardia – post-cardiac surgery-associated RVOT sternal adhesion.
Rajiv Handa, MD, and Barry A. Bryant, CCDS present a case in which it was crucial to reduce the number of leads in the patient’s vasculature while still delivering optimal CRT therapy.
In this month’s issue, Sean Mazer, MD and colleagues highlight their cardiac electrophysiology program in Albuquerque, New Mexico.
Jim Collins, CPC, CCC discusses the evolution of EP coding, and how it will continue to change as new technology and procedural techniques become mainstream.
Shannon Gleason, DNP and colleagues review practical x-ray exposure reduction recommendations, including the choice of protective aprons as well as the use of shields and fluoroscopy settings.